Mead Johnson Nutrition Company company logo

# 1st Gen Model Mead Johnson Nutrition Company Food & kindred products

Subscribe >> Deal exit on
June 15, 2017
Deal entry on
June 15, 2017
0.01%Expected margin
60.87% successful of 46 deals
$89.98 Last close price
at 14-jun-2017

MJN

Model's trade recommendations 0.16% Return for period

-4.91% Annual return

$16.52B Market Cap

β 1.57  

MJN

Model (following trade recommendations)

MJN

Underlying stock

S&P 500

Index
Return for period 0.16%
1.14%
1.78%
52wk return -8.26%
6.05%
16.82%
52wk Range
69.50—93.00
2000.54—2399.63
Sortino ratio -0.54
Sharpe ratio -0.47
Norm. RMSE 0.05%
Downside risk 8.94%
Volatility 10.23%
  • 1.65 (1.83%) Div (Yield)
  • HOLD Analysts consensus recommendation

Mead Johnson, a global leader in pediatric nutrition, develops, manufactures, markets and distributes more than 70 products in over 50 markets worldwide. The company's mission is to nourish the world's children for the best start in life. The Mead Johnson name has been associated with science-based pediatric nutrition products for over 100 years. The company's `Enfa` family of brands, including Enfamil? infant formula, is the world's leading brand franchise in pediatric nutrition.

Industry sector: Consumer Staples

Sector classification: Food & kindred products

Deep Learning based analysis and prediction model for Mead Johnson Nutrition Company (MJN) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Sept. 30, 2015.

Market data for MJN model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 183M
P/E 27.02
Shares Outstanding 184M
% Held by Insiders 0.50%
% Held by Institutions 88.40%
EPS (last reported FY) $3.40
EPS (last reported Q) $0.80
EPS, estimated (last reported Q) $0.82
Total revenues $4 B
Net income $1 B